Article and Video CATEGORIES

Cancer Journey

Search By

2020 MELANOMA - POSTOW - Future Prospects for Immunotherapy Agents in Advanced Melanoma
dbrock
2020 MELANOMA - Future Prospects for Immunotherapy Agents in Advanced Melanoma
Author
GRACE Videos and Articles
Image
GRACE is excited to bring you a new series on current updates in Melanoma Treatment.

Meredith McKean MD, MPH with Tennessee Oncology, Michael Postow, MD Chief of Melanoma Service at Memorial Sloan Kettering, and Sanjiv Agarwala, MD, Professor of Medical Oncology and Hematology at Temple University School of Medicine in Easton, PA joined GRACE to discuss current updates in treatment for Melanoma.

In this video, Dr. Postow discusses future prospects for immunotherapy agents in advanced melanoma.

 

A huge thank you to Merck for sponsoring this program.

Merck

 

To join the conversation, visit https://cancergrace.org/forum.

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Hi Stan!  So good to hear from you.  I'm sorry for the late response.  I too have been out of town with family and missed your post, probably because I was...

Recent Comments

JOIN THE CONVERSATION
ADCs/Antibody-Drug Conjugates
By JanineT GRACE … on
Hi Stan! Good to hear from you.
By JanineT GRACE … on
ROS 1
By JanineT GRACE … on
Hi siigs, I'm sorry you're…
By JanineT GRACE … on